Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Labcorp (LH)

NYSE Health Care Health Care Services S&P 500
$366.57
+3.27 (+0.90%)
Close of Nov 06, 2026 · end-of-day data
Source: Labcorp's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$9.55B$10.31B$11.33B$11.55B$13.98B$13.14B$11.86B$12.16B$13.01B$13.95B
Cost of revenue$6.70B$7.22B$8.16B$8.30B$9.03B$8.14B$8.15B$8.80B$9.38B$9.94B
Gross profit$2.85B$3.09B$3.18B$3.25B$4.95B$4.99B$3.71B$3.36B$3.62B$4.01B
Selling, general & admin$1.35B$1.50B$1.57B$1.62B$1.73B$1.69B$1.76B$2.02B$2.23B$2.22B
Operating income$1.27B$1.31B$1.33B$1.33B$2.45B$3.05B$1.44B$725.60M$1.09B$1.38B
Interest expense$219.10M$235.10M$244.20M$240.70M$207.40M$211.80M$179.80M$199.60M$208.30M$224.10M
Income tax$360.70M-$155.40M$384.40M$280.00M$662.10M$690.00M$233.90M$188.50M$212.40M$229.80M
Net income$711.80M$1.23B$883.70M$823.80M$1.56B$2.38B$1.28B$418.00M$746.00M$876.50M
EBITDA$1.77B$1.84B$1.88B$1.91B$3.07B$3.63B$1.97B$1.30B$1.73B$2.07B
EPS (basic)$6.94$11.99$8.71$8.42$15.99$24.60$14.05$4.80$8.89$10.54
EPS (diluted)$6.82$11.81$8.61$8.35$15.88$24.39$13.97$4.77$8.84$10.46
Diluted shares104.30M103.90M102.60M98.60M98.00M97.50M91.60M87.60M84.40M83.80M
Gross margin29.9%30.0%28.0%28.1%35.4%38.0%31.3%27.7%27.9%28.8%
Operating margin13.3%12.7%11.7%11.5%17.5%23.2%12.1%6.0%8.4%9.9%
Net margin7.5%11.9%7.8%7.1%11.1%18.1%10.8%3.4%5.7%6.3%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$433.60M$316.60M$426.80M$337.50M$1.32B$1.47B$320.60M$536.80M$1.52B$532.30M
Receivables$1.33B$1.53B$1.47B$1.54B$2.48B$2.26B$1.79B$1.91B$1.94B$2.10B
Inventory$205.20M$227.20M$237.30M$244.70M$423.20M$401.40M$470.60M$474.60M$493.20M$534.70M
Total current assets$2.48B$2.73B$2.84B$2.98B$5.13B$5.33B$4.62B$3.77B$4.81B$4.02B
Goodwill$6.42B$7.40B$7.36B$7.87B$7.75B$5.89B$6.12B$6.14B$6.37B$6.79B
Total assets$14.25B$16.67B$16.19B$18.05B$20.07B$20.39B$20.16B$16.73B$18.38B$18.39B
Total current liabilities$1.83B$2.19B$1.88B$2.66B$3.08B$2.78B$3.08B$3.23B$3.33B$2.82B
Short-term debt$549.50M$417.50M$10.00M$415.20M$376.70M$1.50M$301.30M$999.80M$1.00B$500.10M
Long-term debt$5.30B$6.34B$5.99B$5.79B$5.42B$5.42B$5.04B$4.05B$5.33B$5.08B
Total debt$5.85B$6.76B$6.00B$6.21B$5.80B$5.42B$5.34B$5.05B$6.33B$5.58B
Total liabilities$8.73B$9.85B$9.19B$10.46B$10.61B$10.09B$10.04B$8.83B$10.31B$9.76B
Shareholders' equity$5.52B$6.80B$7.05B$7.64B$9.44B$10.27B$10.10B$7.88B$8.05B$8.62B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.20B$1.50B$1.31B$1.44B$2.14B$3.11B$1.96B$1.33B$1.59B$1.64B
Capital expenditures$278.90M$312.90M$379.80M$400.20M$381.70M$421.50M$429.30M$453.60M$489.90M$434.50M
Free cash flow$918.20M$1.19B$925.60M$1.04B$1.75B$2.69B$1.53B$874.10M$1.10B$1.21B
Investing cash flow-$795.70M-$2.23B$206.70M-$1.28B-$643.20M-$884.60M-$1.65B-$1.17B-$1.37B-$1.19B
Financing cash flow-$671.00M$593.20M-$1.39B-$252.70M-$517.40M-$2.07B-$1.32B-$59.30M$779.90M-$1.46B
Dividends paid——————$195.20M$254.00M$243.10M$240.70M
Share buybacks$43.90M$338.10M$700.00M$450.00M$100.00M$1.67B$1.10B$1.00B$250.10M$450.00M
Stock-based compensation$109.60M$109.70M$91.60M$107.00M$111.70M$132.90M$116.80M$128.70M$116.70M$125.80M
Depreciation & amortization$499.20M$533.20M$552.10M$577.20M$624.70M$577.00M$537.20M$577.30M$643.50M$681.10M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.